Lilly's Cymbalta Label Adds Postmarketing Data On Hepatotoxicity
This article was originally published in The Pink Sheet Daily
Executive Summary
Revised labeling for Lilly's Cymbalta extends hepatotoxicity Precaution based on postmarketing reports.